EIP Pharma
UEI: ZHHVJ1KU1NA1
• CAGE: 6WEZ1
Overview
Awardee Type
Parent
Company Description
Focusing on treatments for neurodegenerative diseases like Alzheimer’s, Dementia with Lewy Bodies, and Huntington’s disease.
Name
EIP Pharma
Website
Headquarters
Philadelphia, PA
United States
United States
Most Recent Award
Feb. 1, 2023
Calculating
Federal grant recipient
EIP PHARMA, INC.
(UEI ZHHVJ1KU1NA1, CAGE 6WEZ1)
is headquartered in Philadelphia PA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in July 2010 and
federally registered in
May 2013.
Federal Award Analysis
EIP Pharma federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
EIP PHARMA, INC.
UEI
ZHHVJ1KU1NA1
CAGE Code
6WEZ1
SBA Certifications
None
Self Certifications
Minority Owned Business
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 15, 2010
Initial Registration
May 16, 2013
Last Registration
Oct. 8, 2025
Registration Activation
Oct. 8, 2025
Registration Expiration
Oct. 7, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No